{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:05:17Z","timestamp":1789232717942,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,10]]},"group-title":"Immunology","reference-count":46,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["1U19AI181881"],"award-info":[{"award-number":["1U19AI181881"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Human parainfluenza viruses (HPIVs) can cause severe respiratory illnesses, such as croup, bronchiolitis, and pneumonia, particularly in children, the elderly and immunocompromised individuals. No vaccines or specific therapeutics are available for use in humans. Here, we report the discovery of a human monoclonal antibody designated PVA269 that broadly and potently neutralizes all four HPIV subtypes, PIV5, and Sendai virus by targeting the hemagglutinin-neuraminidase (HN) glycoprotein. We show that PVA269 inhibits neuraminidase activity and hemagglutination of erythrocytes through insertion of a long heavy chain complementary-determining region 3 in the enzyme active site. We reveal that the antibody markedly remodels its interactions to accommodate distinct viral features across HPIV subtypes, such as HPIV2 N-linked glycans. These results define the molecular basis for the unique PVA269 pan-neutralizing activity of human and animal viruses spanning two genera. PVA269 provides potent prophylactic activity against HPIV3 replication in the upper and lower airways of the clinically predictive cotton rat model, thus supporting translation of its protective efficacy to humans. These data establish PVA269 as a best-in-class monoclonal antibody and a promising clinical candidate to prevent HPIV infection, transmission, and disease in vulnerable populations.<\/jats:p>","DOI":"10.64898\/2026.09.07.749649","type":"posted-content","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:05:18Z","timestamp":1789088718000},"source":"Crossref","is-referenced-by-count":0,"title":["Pan-neutralization of parainfluenza viruses by a hemagglutinin-neuraminidase antibody"],"prefix":"10.64898","author":[{"given":"Anna De","family":"Marco","sequence":"first","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Gen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jun","family":"Park","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cusumano","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily","family":"Gibson","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Vyas","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Momont","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Tasin","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Chiara","family":"Galli","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Merz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Giacchetto-Sasselli","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneida","family":"Vetti","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson","family":"Rietz","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Tsu","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yim","sequence":"additional","affiliation":[{"name":"Sigmovir Biosystems, Inc. 9610 Medical Center Dr., #100 Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Blanco","sequence":"additional","affiliation":[{"name":"Sigmovir Biosystems, Inc. 9610 Medical Center Dr., #100 Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Piantanida","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Ospedale Regionale di Lugano, Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Czudnochowski","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Snell","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S.","family":"Boukhvalova","sequence":"additional","affiliation":[{"name":"Sigmovir Biosystems, Inc. 9610 Medical Center Dr., #100 Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Towne","sequence":"additional","affiliation":[{"name":"Vir Biotechnology, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Corti","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Samuele","family":"Pizzuto","sequence":"additional","affiliation":[{"name":"Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-8675","authenticated-orcid":false,"given":"David","family":"Veesler","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Washington, Seattle, WA 98195, USA"},{"name":"Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091209100543000_2026.09.07.749649v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106213442507"},{"key":"2026091209100543000_2026.09.07.749649v1.2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.2.242-264.2003"},{"key":"2026091209100543000_2026.09.07.749649v1.3","unstructured":"CDC. Clinical overview of human Parainfluenza viruses. Parainfluenza https:\/\/www.cdc.gov\/parainfluenza\/hcp\/clinical-overview\/index.html (2026)."},{"key":"2026091209100543000_2026.09.07.749649v1.4","doi-asserted-by":"publisher","DOI":"10.1086\/507638"},{"key":"2026091209100543000_2026.09.07.749649v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.04.012"},{"key":"2026091209100543000_2026.09.07.749649v1.6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41409-022-01575-z","article-title":"Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients","volume":"57","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"2026091209100543000_2026.09.07.749649v1.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271756"},{"key":"2026091209100543000_2026.09.07.749649v1.8","doi-asserted-by":"crossref","unstructured":"Pawe\u0142czyk, M. & Kowalski, M. L . The role of human Parainfluenza virus infections in the immunopathology of the respiratory tract. Curr. Allergy Asthma Rep. 17, 16 (2017).","DOI":"10.1007\/s11882-017-0685-2"},{"key":"2026091209100543000_2026.09.07.749649v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2003.11.032"},{"key":"2026091209100543000_2026.09.07.749649v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2005.02.019"},{"key":"2026091209100543000_2026.09.07.749649v1.11","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01965-12"},{"key":"2026091209100543000_2026.09.07.749649v1.12","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1038\/s41467-024-53082-y","article-title":"How a paramyxovirus fusion\/entry complex adapts to escape a neutralizing antibody","volume":"15","year":"2024","journal-title":"Nat. Commun"},{"key":"2026091209100543000_2026.09.07.749649v1.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25669"},{"key":"2026091209100543000_2026.09.07.749649v1.14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-024-01722-w","article-title":"Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies","volume":"9","year":"2024","journal-title":"Nat. Microbiol"},{"key":"2026091209100543000_2026.09.07.749649v1.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2112186"},{"key":"2026091209100543000_2026.09.07.749649v1.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811980115"},{"key":"2026091209100543000_2026.09.07.749649v1.17","doi-asserted-by":"crossref","unstructured":"McCaffrey, K. D. , Esfahani, B. G. , Elbehairy, M. A. , McCormick, A. L. & Mousa, J. J . Molecular basis for protection and cross-protection by human antibodies targeting the parainfluenza virus hemagglutinin-neuraminidase protein. J. Virol. e0050226 (2026).","DOI":"10.64898\/2026.03.03.709347"},{"key":"2026091209100543000_2026.09.07.749649v1.18","doi-asserted-by":"crossref","unstructured":"Cab\u00e1n, M. et al. Cross-protective antibodies against common endemic respiratory viruses. Nat. Commun. 14, 798 (2023).","DOI":"10.1038\/s41467-023-36459-3"},{"key":"2026091209100543000_2026.09.07.749649v1.19","doi-asserted-by":"crossref","unstructured":"Miller, R. J. et al. The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase. Nat. Commun. 15, 10825 (2024).","DOI":"10.1038\/s41467-024-55101-4"},{"key":"2026091209100543000_2026.09.07.749649v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007731"},{"key":"2026091209100543000_2026.09.07.749649v1.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003534"},{"key":"2026091209100543000_2026.09.07.749649v1.22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm5561"},{"key":"2026091209100543000_2026.09.07.749649v1.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314990121"},{"key":"2026091209100543000_2026.09.07.749649v1.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111691108"},{"key":"2026091209100543000_2026.09.07.749649v1.25","doi-asserted-by":"crossref","first-page":"e2208866120","DOI":"10.1073\/pnas.2208866120","article-title":"Structure and supramolecular organization of the canine distemper virus attachment glycoprotein","volume":"120","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2026091209100543000_2026.09.07.749649v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4169"},{"key":"2026091209100543000_2026.09.07.749649v1.27","unstructured":"Hunt, A. C. et al. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice. Sci. Transl. Med. 14, eabn1252 (2022)."},{"key":"2026091209100543000_2026.09.07.749649v1.28","doi-asserted-by":"crossref","unstructured":"Lee, J. et al. The computationally designed TRI2-2 miniprotein inhibitor protects against multiple SARS-CoV-2 Omicron variants. Commun . Biol. 9, 224 (2026).","DOI":"10.1038\/s42003-025-09499-2"},{"key":"2026091209100543000_2026.09.07.749649v1.29","doi-asserted-by":"crossref","unstructured":"Ragotte, R. J. et al. Designed miniproteins potently inhibit and protect against MERS-CoV. Cell Rep. 44, 115760 (2025).","DOI":"10.1016\/j.celrep.2025.115760"},{"key":"2026091209100543000_2026.09.07.749649v1.30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300880"},{"key":"2026091209100543000_2026.09.07.749649v1.31","doi-asserted-by":"crossref","unstructured":"Boonyaratanakornkit, J. et al. Protective antibodies against human parainfluenza virus type 3 infection. MAbs 13, 1912884 (2021).","DOI":"10.1080\/19420862.2021.1912884"},{"key":"2026091209100543000_2026.09.07.749649v1.32","doi-asserted-by":"crossref","unstructured":"Marcink, T. C. et al. Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms. Sci. Adv. 9, eade2727 (2023).","DOI":"10.1126\/sciadv.ade2727"},{"key":"2026091209100543000_2026.09.07.749649v1.33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.chom.2026.04.010","article-title":"Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins","volume":"34","year":"2026","journal-title":"Cell Host Microbe"},{"key":"2026091209100543000_2026.09.07.749649v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06136-y"},{"key":"2026091209100543000_2026.09.07.749649v1.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay0678"},{"key":"2026091209100543000_2026.09.07.749649v1.36","doi-asserted-by":"publisher","DOI":"10.1086\/514115"},{"key":"2026091209100543000_2026.09.07.749649v1.37","doi-asserted-by":"crossref","unstructured":"Zhu, Q. et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci. Transl. Med. 9, eaaj1928 (2017).","DOI":"10.1126\/scitranslmed.aaj1928"},{"key":"2026091209100543000_2026.09.07.749649v1.38","doi-asserted-by":"publisher","DOI":"10.1017\/s1431927620021194"},{"key":"2026091209100543000_2026.09.07.749649v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07215-4"},{"key":"2026091209100543000_2026.09.07.749649v1.40","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"2026091209100543000_2026.09.07.749649v1.41","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798319011471\/HTTPS:\/\/GOLDBOOK.IUPAC.ORG\/E02002.HTML"},{"key":"2026091209100543000_2026.09.07.749649v1.42","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3330"},{"key":"2026091209100543000_2026.09.07.749649v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3115"},{"key":"2026091209100543000_2026.09.07.749649v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTZ921"},{"key":"2026091209100543000_2026.09.07.749649v1.45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkf436"},{"key":"2026091209100543000_2026.09.07.749649v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst010"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.07.749649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:10:21Z","timestamp":1789229421000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.07.749649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":46,"URL":"https:\/\/doi.org\/10.64898\/2026.09.07.749649","relation":{},"subject":[],"published":{"date-parts":[[2026,9,10]]},"subtype":"preprint"}}